BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
40 results:

  • 1. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
    Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
    Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
    Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
    Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
    Kovács SA; Fekete JT; Győrffy B
    Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse gastric cancer.
    Liu ZX; Zhang XL; Zhao Q; Chen Y; Sheng H; He CY; Sun YT; Lai MY; Wu MQ; Zuo ZX; Wang W; Zhou ZW; Wang FH; Li YH; Xu RH; Qiu MZ
    JAMA Netw Open; 2022 Dec; 5(12):e2245836. PubMed ID: 36484990
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel insights into immunohistochemical analysis for diagnosing serous neoplasm of the pancreas: aquaporin 1, stereocilin, and transmembrane protein 255B.
    Watase C; Fuse M; Ino Y; Naito C; Hiraoka N
    Histopathology; 2021 Nov; 79(5):872-879. PubMed ID: 34288030
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2.
    Du G; Jiang J; Wu Q; Henning NJ; Donovan KA; Yue H; Che J; Lu W; Fischer ES; Bardeesy N; Zhang T; Gray NS
    Angew Chem Int Ed Engl; 2021 Jul; 60(29):15905-15911. PubMed ID: 33915015
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparative effectiveness of treatment modalities in non-metastatic gastric adenocarcinoma: a propensity score matching analysis of the National cancer Database.
    Barzi A; Yang D; Kim AW; Shah MA; Sadeghi S
    BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33148789
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. fgfr3
    Cell Death Dis; ; . PubMed ID: 33097695
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 2.